The DOI matches its Crossref record; 99 of the 100 references it cites were found in a registry or an index.
Progress and challenges in translating the biology of atherosclerosis
Abstract
Atherosclerosis is a chronic disease of the arterial wall, and a leading cause of death and loss of productive life years worldwide. Research into the disease has led to many compelling hypotheses about the pathophysiology of atherosclerotic lesion formation and of complications such as myocardial infarction and stroke. Yet, despite these advances, we still lack definitive evidence to show that processes such as lipoprotein oxidation, inflammation and immunity have a crucial involvement in human atherosclerosis. Experimental atherosclerosis in animals furnishes an important research tool, but extrapolation to humans requires care. Understanding how to combine experimental and clinical science will provide further insight into atherosclerosis and could lead to new clinical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These symptoms are thought to further exacerbate inflammation and, in doing so, contribute to the pathogenesis of various diseases of aging (6–8), many of which involve excessive cytokine activity (9, 10).”
From Clustering of depression and inflammation in adolescents previously exposed to childhood adversity (2012) · cites this paper as [10]
In the citing paper
“Atherosclerosis originates from damaged endothelium that allows the accumulation of cholesterol-containing LDL particles in the arterial wall that tend to be oxidized, which triggers an inflammatory response that fails to resolve”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [144]
In the citing paper
“These limitations are among the reasons that have motivated several groups to issue recommendations for accelerating the translation of nanoparticles into the clinic158,161,162.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [162]
Citations
Cites
1 retracted
Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted
Kawakami, A., Osaka, M., Aikawa, M., Uematsu, S., Akira, S., Libby, P., Shimokado, K., Sacks, F. M., & Yoshida, M. (2008) · Circulation Research · doi:10.1161/circresaha.108.178426 · Cited by 76
Self-citationRetractedInflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Self-citationEffects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Self-citationIntensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 1×
“Clinical trials of one agent with PPAR-α-stimulating activity, gemfibrozil, have shown a reduction in cardiovascular event”
BackgroundRosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Self-citation
Flagged first, then by citations
1 of the 100 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,007
Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques
Langley, S. R., Willeit, K., Didangelos, A., Matic, L. P., Skroblin, P., Barallobre-Barreiro, J., Lengquist, M., Rungger, G., Kapustin, A., Kedenko, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci86924 · Cited by 174
Tang, W. H. W., Hartiala, J., Fan, Y., Wu, Y., Stewart, A. F. R., Erdmann, J., Kathiresan, S., Roberts, R., McPherson, R., Allayee, H., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.253930 · Cited by 173
Hibino, M., Otaki, Y., Kobeissi, E., Pan, H., Hibino, H., Taddese, H., Majeed, A., Verma, S., Konta, T., Yamagata, K., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056546 · Cited by 173
Inouye, M., Ripatti, S., Kettunen, J., Lyytikäinen, L., Oksala, N., Laurila, P., Kangas, A. J., Soininen, P., Savolainen, M. J., Viikari, J. S. A., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002907 · Cited by 168
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
Goldfine, A. B., & Shoelson, S. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88884 · Cited by 176
A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus
Simion, V., Zhou, H., Haemmig, S., Pierce, J. B., Mendes, S., Tesmenitsky, Y., Pérez‐Cremades, D., Lee, J. F., Chen, A. F., Ronda, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19664-2 · Cited by 176
LncRNAs in vascular biology and disease
Simion, V., Haemmig, S., & Feinberg, M. W. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.01.003 · Cited by 174
Phytochemistry and cardiovascular protective effects of Huang‐Qi (Astragali Radix)
Su, H., Shaker, S., Kuang, Y., Zhang, M., Ye, M., & Qiao, X. (2021) · Medicinal Research Reviews · doi:10.1002/med.21785 · Cited by 172
Liu, W.-W., Zheng, S.-Q., Tian, L., Fei, Y.-F., Wang, C., Zhang, S., Wang, F., Jiang, G., & Wang, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01777-5 · Cited by 187
Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis
Chen, Q., Lv, J., Yang, W., Xu, B., Wang, Z., Yu, Z., Wu, J., Yang, Y., & Han, Y. (2019) · Theranostics · doi:10.7150/thno.35528 · Cited by 174
van der Valk, F. M., van Wijk, D. F., Lobatto, M. E., Verberne, H. J., Storm, G., Willems, M. C. M., Legemate, D. A., Nederveen, A. J., Calcagno, C., Mani, V., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.02.021 · Cited by 173
Cardiovascular Disease and Alzheimer's Disease: The Heart–Brain Axis
Saeed, A., López, O. L., Cohen, A. D., & Reís, S. E. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030780 · Cited by 181
Kelly, F. J., & Fussell, J. C. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.06.019 · Cited by 171
Inflammation as a Therapeutic Target in Atherosclerosis
Nguyen, M. T., Fernando, S., Schwarz, N., Tan, J. T. M., Bursill, C. A., & Psaltis, P. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081109 · Cited by 176
HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages
Sánchez-Gaytán, B. L., Fay, F., Lobatto, M. E., Tang, J., Ouimet, M. I., Kim, Y., van der Staay, S. E. M., van Rijs, S. M., Priem, B., Zhang, L., et al. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500517k · Cited by 172
A Systems Biology Framework Identifies Molecular Underpinnings of Coronary Heart Disease
Huan, T., Zhang, B., Wang, Z., Joehanes, R., Zhu, J., Johnson, A. D., Ying, S., Munson, P. J., Raghavachari, N., Wang, R., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300112 · Cited by 167
Fasolo, F., Jin, H., Winski, G., Chernogubova, E., Pauli, J., Winter, H., Li, D. Y., Glukha, N., Bauer, S., Metschl, S., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.052023 · Cited by 167
Miller, G. E., Murphy, M. L. M., Cashman, R., Ma, R., Ma, J., Arevalo, J. M. G., Kobor, M. S., & Cole, S. W. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.016 · Cited by 166
Giménez‐Bastida, J. A., González‐Sarrías, A., Larrosa, M., Tomás-Barberán, F. A., Espı́n, J. C., & García‐Conesa, M. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100677 · Cited by 166
Monocyte subpopulations and cardiovascular risk in chronic kidney disease
Heine, G. H., Ortíz, A., Massy, Z. A., Lindholm, B., Więcek, A., Martínez‐Castelao, A., Covic, A. C., Goldsmith, D. J. A., Süleymanlar, G., London, G. M., et al. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.41 · Cited by 171
Efferocytosis in atherosclerosis
Adkar, S. S., & Leeper, N. J. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01037-7 · Cited by 182
Bruckman, M. A., Jiang, K., Simpson, E. J., Randolph, L. N., Luyt, L. G., Yu, X., & Steinmetz, N. F. (2014) · Nano Letters · doi:10.1021/nl404816m · Cited by 165
Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models
Ammirati, E., Cianflone, D., Vecchio, V., Banfi, M., Vermi, A. C., Metrio, M. D., Grigore, L., Pellegatta, F., Pirillo, A., Garlaschelli, K., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.111.000125 · Cited by 170
Tse, K. Y., Tse, H. Y., Sidney, J., Sette, A., & Ley, K. F. (2013) · International Immunology · doi:10.1093/intimm/dxt043 · Cited by 171
Targeting inflammation to reduce cardiovascular disease risk: A realistic clinical prospect?
Welsh, P., Grassia, G., Botha, S., Sattar, N., & Maffia, P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13818 · Cited by 164
Vascular tissue engineering: from in vitro to in situ
Li, S., Sengupta, D., & Chien, S. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1246 · Cited by 173
Elosúa, R., Sayols-Baixeras, S., Lluís-Ganella, C., & Lucas, G. (2014) · The Application of Clinical Genetics · doi:10.2147/tacg.s35301 · Cited by 169
Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis
Lin, L., Zhang, M.-X., Zhang, L., Zhang, D., Li, C., & Li, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809955 · Cited by 166
The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases
Izzo, C., Vitillo, P., Pietro, P. D., Visco, V., Strianese, A., Virtuoso, N., Ciccarelli, M., Galasso, G., Carrizzo, A., & Vecchione, C. (2021) · Life · doi:10.3390/life11010060 · Cited by 177
Fanola, C. L., Morrow, D. A., Cannon, C. P., Jarolím, P., Lukas, M. A., Bode, C., Hochman, J. S., Goodrich, E. L., Braunwald, E., & O’Donoghue, M. L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005637 · Cited by 167
Unstressing intemperate models: how cold stress undermines mouse modeling
Karp, C. L. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120988 · Cited by 161
Platelet-Derived Microvesicles in Cardiovascular Diseases
Zaldivia, M. T. K., McFadyen, J. D., Lim, B., Wang, X., & Peter, K. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00074 · Cited by 159
Progress in TiO 2 nanotube coatings for biomedical applications: a review
Cheng, Y. F., Yang, H. D., Yang, Y., Huang, J., Wu, K., Chen, Z., Wang, X., Lin, C., & Lai, Y. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00149a · Cited by 168
Biological Relevance of Inflammation and Oxidative Stress in the Pathogenesis of Arterial Diseases
Hajjar, D. P., & Gotto, A. M. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.010 · Cited by 159
Is atherosclerosis an autoimmune disease?
Matsuura, E., Atzeni, F., Sarzi‐Puttini, P., Turiel, M., Lopez, L. R., & Nurmohamed, M. T. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-47 · Cited by 158
FOXOs and Sirtuins in Vascular Growth, Maintenance, and Aging
Oellerich, M. F., & Potente, M. (2012) · Circulation Research · doi:10.1161/circresaha.111.246488 · Cited by 161
Recio, C., Lucy, D., Purvis, G. S. D., Iveson, P., Zeboudj, L., Iqbal, A. J., Lin, D., O’Callaghan, C. A., Davison, L. J., Griesbach, E., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01419 · Cited by 166
BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs
Borck, P. C., Guo, L., & Plutzky, J. (2020) · Circulation Research · doi:10.1161/circresaha.120.315929 · Cited by 155
Bone Morphogenetic Proteins in Vascular Homeostasis and DiseasePreprint
Goumans, M., Zwijsen, A., ten Dijke, P., & Bailly, S. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a031989 · Cited by 173
Pathophysiology, presentation, prognosis, and management of intracranial arterial dolichoectasia
Pico, F., Labreuche, J., & Amarenco, P. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00089-7 · Cited by 156
Increased Burden of Cardiovascular Disease in Carriers of APOL1 Genetic Variants
Ito, K., Bick, A. G., Flannick, J. A., Friedman, D. J., Genovese, G., Parfenov, M. G., DePalma, S. R., Gupta, N., Gabriel, S., Taylor, H. A., et al. (2013) · Circulation Research · doi:10.1161/circresaha.114.302347 · Cited by 156
Mahmoud, A. D., Ballantyne, M. D., Miscianinov, V., Pinel, K., Hung, J., Scanlon, J. P., Iyinikkel, J., Kaczynski, J., Tavares, A., Bradshaw, A. C., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.314876 · Cited by 155
Mitochondria in vascular disease
Yu, E., Mercer, J. R., & Bennett, M. R. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs111 · Cited by 153
Psychosocial Factors in Diabetes and Cardiovascular Risk
Hackett, R. A., & Steptoe, A. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0771-4 · Cited by 152
Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis
Aarup, A., Pedersen, T. X., Junker, N., Christoffersen, C., Bartels, E. D., Madsen, M., Nielsen, C. H., & Nielsen, L. B. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307830 · Cited by 159
Zhang, X., Zhang, Y., Wang, P., Zhang, S., Dong, Y., Zeng, G., Yan, Y., Sun, L., Wu, Q., Liu, H., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.016 · Cited by 154
Han, X., & Boisvert, W. A. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-06-0509 · Cited by 151
TGFβ Signaling and Cardiovascular Diseases
Pardali, E., & ten Dijke, P. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.8.195 · Cited by 151
Role of Nrf2 in the pathogenesis of atherosclerosis
Mimura, J., & Itoh, K. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.019 · Cited by 156
He, C., Medley, S. C., Hu, T., Hinsdale, M. E., Lupu, F., Virmani, R., & Olson, L. E. (2015) · Nature Communications · doi:10.1038/ncomms8770 · Cited by 150
Cardiovascular Risk in Type 1 Diabetes Mellitus
Schofield, J. D., Ho, J. H., & Soran, H. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0612-8 · Cited by 164
Fan, Z., Tang, P., Li, C., Yang, Q., Xu, Y., Su, C., & Li, L. (2023) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2145729 · Cited by 150
Elmarasi, M., Elmakaty, I., Elsayed, B., Elsayed, A., Zein, J. A., Boudaka, A., & Eid, A. H. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31200 · Cited by 159
Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells
Kim, S. A., & Choi, H. C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.165 · Cited by 149
Gene expression signatures, pathways and networks in carotid atherosclerosis
Matic, L. P., Aldi, S., Sun, Y., Folkersen, L., Razuvaev, A., Roy, J., Lengquist, M., Åkesson, S., Wheelock, C. E., Mäegdefessel, L., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12448 · Cited by 145
Self-citationInflammation and Atherosclerosis
Hansson, G. K. (2017) · Circulation · doi:10.1161/circulationaha.117.030484 · Cited by 149
Self-citationMast Cells as Effectors in Atherosclerosis
Bot, I., Shi, G., & Kovanen, P. T. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303570 · Cited by 153
Role of vascular smooth muscle cell in the inflammation of atherosclerosis
Lim, S., & Park, S. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.1.285 · Cited by 149
Infection and atherosclerosis: TLR-dependent pathways
Li, B., Xia, Y., & Hu, B. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03453-7 · Cited by 149
Cardiovascular disease in inflammatory rheumatic diseases
Castañeda, S., Nurmohamed, M. T., & González-Gay, M. Á. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.10.006 · Cited by 146
The role of smooth muscle cells in plaque stability: Therapeutic targeting potential
Harman, J. J., & Jørgensen, H. F. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14779 · Cited by 147
Hydroxytyrosol and Potential Uses in Cardiovascular Diseases, Cancer, and AIDS
Vilaplana-Pérez, C., Auñón, D., García-Flores, L. A., & Gil‐Izquierdo, Á. (2014) · Frontiers in Nutrition · doi:10.3389/fnut.2014.00018 · Cited by 152
HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis
de Souza, A. W. S., Westra, J., Limburg, P. C., Bijl, M., & Kallenberg, C. G. M. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.03.007 · Cited by 145
Cardiovascular diseases related to ionizing radiation: The risk of low-dose exposure (Review)
Baselet, B., Rombouts, C., Benotmane, M. A., Baatout, S., & Aerts, A. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2777 · Cited by 151
Atherosclerosis and Cancer; A Resemblance with Far-reaching Implications
Tapia-Vieyra, J. V., Delgado‐Coello, B., & Mas‐Oliva, J. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.03.005 · Cited by 141
Cardiovascular toxicity and mechanism of bisphenol A and emerging risk of bisphenol S
Zhang, Y., Shan, C., Wang, Y., Qian, L.-L., Jia, D., Zhang, Y., Hao, X., & Xu, H. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.137952 · Cited by 147
HIV Proteins and Endothelial Dysfunction: Implications in Cardiovascular Disease
Anand, A. R., Rachel, G., & Parthasarathy, D. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00185 · Cited by 142
Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling
Adachi, Y., Ueda, K., Nomura, S., Ito, K., Katoh, M., Katagiri, M., Yamada, S., Hashimoto, M., Zhai, B., Numata, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32658-6 · Cited by 142
Laguna-Fernandez, A., Checa, A., Carracedo, M., Artiach, G., Petri, M. H., Baumgartner, R., Forteza, M. J., Jiang, X., Andonova, T., Walker, M. E., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032801 · Cited by 141
Self-citationQin, J., Peng, Z., Li, B., Ye, K., Zhang, Y., Yuan, F., Yang, X., Huang, L., Hu, J., & Lu, X. (2015) · Nanoscale · doi:10.1039/c5nr02521d · Cited by 141
The critical role of endothelial function in fine particulate matter-induced atherosclerosis
Liang, S., Zhang, J., Ning, R., Du, Z., Liu, J., Batibawa, J. W., Duan, J., & Sun, Z. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00391-x · Cited by 145
Mohanta, S. K., Yin, C., Peng, L., Srikakulapu, P., Bontha, S. V., Hu, D., Weih, F., Weber, C., Gerdes, N., & Habenicht, A. J. R. (2014) · Circulation Research · doi:10.1161/circresaha.114.301137 · Cited by 140
Tsimikas, S., Duff, G. W., Berger, P. B., Rogus, J. J., Huttner, K. M., Clopton, P., Brilakis, E. S., Kornman, K. S., & Witztum, J. L. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.12.030 · Cited by 140
Multiscale technologies for treatment of ischemic cardiomyopathy
Mahmoudi, M., Yu, M., Serpooshan, V., Wu, J. C., Langer, R., Lee, R. T., Karp, J. M., & Farokhzad, O. C. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.167 · Cited by 140
CD36 and lipid metabolism in the evolution of atherosclerosis
Zhao, L., Varghese, Z., Moorhead, J. F., Chen, Y., & Ruan, X. Z. (2018) · British Medical Bulletin · doi:10.1093/bmb/ldy006 · Cited by 140
Association between the weight-adjusted waist index and stroke: a cross-sectional study
Ye, J., Hu, Y., Chen, X., Yin, Z., Yuan, X., Huang, L., & Li, K. (2023) · BMC Public Health · doi:10.1186/s12889-023-16621-8 · Cited by 140
Wei, Y., Wu, Y., Zhao, R., Zhang, K., Midgley, A. C., Kong, D., Li, Z., & Zhao, Q. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.049 · Cited by 140
Frambach, S. J. C. M., de Haas, R., Smeitink, J. A. M., Rongen, G. A. P. J. M., Rüssel, F. G. M., & Schirris, T. J. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017897 · Cited by 146
Ntsekhe, M., & Baker, J. V. (2022) · Circulation · doi:10.1161/circulationaha.122.057443 · Cited by 144
The Role of Fetuin-A in Physiological and Pathological Mineralization
Brylka, L., & Jahnen‐Dechent, W. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9690-6 · Cited by 138
Lutein exerts anti-inflammatory effects in patients with coronary artery disease
Chung, R. W. S., Leanderson, P., Lundberg, A. K., & Jonasson, L. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.05.008 · Cited by 135
Long noncoding RNA SNHG12 integrates a DNA-PK–mediated DNA damage response and vascular senescence
Haemmig, S., Yang, D., Sun, X., Das, D., Ghaffari, S., Molinaro, R., Chen, L., Deng, Y., Freeman, D., Moullan, N., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1868 · Cited by 142
Self-citationZmysłowski, A., & Szterk, A. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0579-2 · Cited by 139
Zeng, Z., Quan, X., Yu, H., Chen, S., Zhang, Y., Zhao, H., & Zhang, S. (2018) · Applied Catalysis B: Environmental · doi:10.1016/j.apcatb.2018.05.003 · Cited by 136
TGFβ Signaling and Cardiovascular Diseases
Pardali, E., & ten Dijke, P. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.3805 · Cited by 177
Liver X receptors at the intersection of lipid metabolism and atherogenesis
Lee, S. D., & Tontonoz, P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.042 · Cited by 135
Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury
Riegler, J., Liew, A., Hynes, S. O., Ortega, D., O’Brien, T., Day, R. M., Richards, T., Sharif, F., Pankhurst, Q. A., & Lythgoe, M. F. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.040 · Cited by 135
Atherosclerosis and immunity: A perspective
Abdolmaleki, F., Hayat, S. M. G., Bianconi, V., Johnston, T. P., & Sahebkar, A. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.09.017 · Cited by 138
Sanches-Silva, A. T., Testai, L., Nabavi, S. F., Battino, M. A., Devi, K. P., Tejada, S., Sureda, A., Xu, S., Yousefi, B., Majidinia, M., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104626 · Cited by 135
A bibliometric analysis of T cell and atherosclerosis
Wei, N., Xu, Y., Li, Y., Shi, J., Zhang, X., You, Y., Sun, Q., Zhai, H., & Hu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.948314 · Cited by 141
The Role of Sleep in Cardiovascular Disease
Jaspan, V. N., Greenberg, G. S., Parihar, S., Park, C. M., Somers, V. K., Shapiro, M. D., Lavie, C. J., Virani, S. S., & Slipczuk, L. N. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01207-5 · Cited by 150
The biology of the platelet with special reference to inflammation wound healing and immunity
Nurden, A. T. (2017) · Frontiers in bioscience · doi:10.2741/4613 · Cited by 137
Targeting cannabinoid receptor CB2in cardiovascular disorders: promises and controversies
Steffens, S., & Pacher, P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02042.x · Cited by 137
Monocyte heterogeneity in human cardiovascular disease
Zawada, A. M., Rogacev, K. S., Schirmer, S. H., Sester, M., Böhm, M., Fliser, D., & Heine, G. H. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.001 · Cited by 132
Vascular disease and dementias: Paradigm shifts to drive research in new directions
Kling, M. A., Trojanowski, J. Q., Wolk, D. A., Lee, V. M. ‐., & Arnold, S. E. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.02.007 · Cited by 137
He, L., Zhou, Q., Huang, Z., Xu, J., Zhou, H., Lv, D., Lu, L., Huang, S., Tang, M., Zhong, J., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27527 · Cited by 137
Endothelial progenitor cells in atherosclerosis
Du, F. (2012) · Frontiers in bioscience · doi:10.2741/4055 · Cited by 133
Hypertensive heart disease: risk factors, complications and mechanisms
Masenga, S. K., & Kirabo, A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1205475 · Cited by 178
Endothelial MicroRNAs and Atherosclerosis
Sun, X., Belkin, N., & Feinberg, M. W. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0372-2 · Cited by 134
Postprandial lipoproteins and the molecular regulation of vascular homeostasis
Botham, K. M., & Wheeler-Jones, C. P. D. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.06.001 · Cited by 137
Metadata
- Authors
- Libby, P., Ridker, P. M., & Hansson, G. K.
- Affiliations
- Brigham and Women's Hospital (US)
- Karolinska University Hospital (SE)
- Corresponding author
- Libby, Peter
- Venue
- Nature
- Published
- 2011-05
- Volume
- 473
- Issue
- 7347
- Pages
- 317-325
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2033896075
- Semantic Scholar
- 31a83a618339a5f25357342f3633f5a423880eb6
- Cited by
- 4,010
- References
- 100
- Citations by year
- 2026: 169 · 2025: 235 · 2024: 252 · 2023: 249 · 2022: 283 · 2021: 342 · 2020: 299 · 2019: 264 · 2018: 271 · 2017: 304 · 2016: 271 · 2015: 286 · 2014: 258 · 2013: 232 · 2012: 230
- FWCI
- 22.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherosclerosis, atherosclerotic plaque formation, lipoprotein oxidation, inflammation, immunity, animal models, animal-to-human extrapolation, myocardial infarction, stroke, translational research
- MeSH terms
- Animals, Humans, Inflammation, Cholesterol, HDL, Cholesterol, LDL, Triglycerides, Atherosclerosis, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review